Abstract
Hyaluronic acid, a high-molecular-weight biopolymer, is of special interest as carrier material in drug delivery due to its biocompatibility, biodegradability, special viscoelastic properties, as well as its ability to create a dense network in which drugs might be incorporated. Hyaluronic acid has a broad applicability in various conditions such as in cosmetic products in terms of anti-wrinkle treatment and skin hydration, local drug delivery, intra-articular injection into arthritic joints and visco-supplementation in ophthalmology.
This chapter focuses on the use of hyaluronic acid-based formulations in cosmetics as well as for intra-/transdermal delivery of drugs. We elucidate the role of hyaluronic acid/fragments as a skin penetration enhancer and tried to highlight the properties of hyaluronic acid which make them unique in the field of drug delivery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alam CA, Seed MP, Willoughby DA (1995) Angiostasis and vascular regression in chronic granulomatous inflammation induced by diclofenac in combination with hyaluronan in mice. J Pharm Pharmacol 47(5):407–411
Barnes L, Tran C, Sorg O, Hotz R, Grand D, Carraux P et al (2010) Synergistic effect of hyaluronate fragments in retinaldehyde-induced skin hyperplasia which is a Cd44-dependent phenomenon. PLoS One 5(12), e14372
Birkenfeld B, Parafiniuk M, Bielecka-Grzela S, Klimowicz A, Piwowarska-Bilska H, Mikolajczak R et al (2011) The penetration of topically applied ointment containing hyaluronic acid in rabbit tissues. Pol J Vet Sci 14(4):621–627
Boateng JS, Matthews KH, Stevens HN, Eccleston GM (2008) Wound healing dressings and drug delivery systems: a review. J Pharm Sci 97(8):2892–2923
Bourguignon LY, Singleton PA, Diedrich F (2004) Hyaluronan-CD44 interaction with Rac1-dependent protein kinase N-gamma promotes phospholipase Cgamma1 activation, Ca(2+) signaling, and cortactin-cytoskeleton function leading to keratinocyte adhesion and differentiation. J Biol Chem 279(28):29654–29669
Brown MB, Hanpanitcharoen M, Martin GP (2001) An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs. Int J Pharm 225(1-2):113–121
Brown MB, Jones SA (2005) Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol Venereol 19(3):308–318
Brown MB, Marriott C, Martin GP (1995) The effect of hyaluronan on the in vitro deposition of diclofenac within the skin. Int J Tissue React 17(4):133–140
Brown TJ, Alcorn D, Fraser JR (1999) Absorption of hyaluronan applied to the surface of intact skin. J Invest Dermatol 113(5):740–746
Chen WY, Marcellin E, Hung J, Nielsen LK (2009) Hyaluronan molecular weight is controlled by UDP-N-acetylglucosamine concentration in Streptococcus zooepidemicus. J Biol Chem 284(27):18007–18014
Colletta V, Dioguardi D, Di Lonardo A, Maggio G, Torasso F (2003) A trial to assess the efficacy and tolerability of Hyalofill-F in non-healing venous leg ulcers. J Wound Care 12(9):357–360
Cordero A, Leon-Dorantes G, Pons-Guiraud A, Di Pietro A, Asensi SV, Walkiewicz-Cyraska B et al (2011) Retinaldehyde/hyaluronic acid fragments: a synergistic association for the management of skin aging. J Cosmet Dermatol 10(2):110–117
Costagliola M, Agrosi M (2005) Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs. silver sulfadiazine alone. Curr Med Res Opin 21(8):1235–1240
Dusio GF, Cardani D, Zanobbio L, Mantovani M, Luchini P, Battini L et al (2011) Stimulation of TLRs by LMW-HA induces self-defense mechanisms in vaginal epithelium. Immunol Cell Biol 89(5):630–639
Farwick M, Gauglitz G, Pavicic T, Kohler T, Wegmann M, Schwach-Abdellaoui K et al (2011) Fifty-kDa hyaluronic acid upregulates some epidermal genes without changing TNF-alpha expression in reconstituted epidermis. Skin Pharmacol Physiol 24(4):210–217
Gao F, Liu Y, He Y, Yang C, Wang Y, Shi X et al (2010) Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 29(2):107–116
Greco RM, Iocono JA, Ehrlich HP (1998) Hyaluronic acid stimulates human fibroblast proliferation within a collagen matrix. J Cell Physiol 177(3):465–473
Hall CL, Wang C, Lange LA, Turley EA (1994) Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 126(2):575–588
Ito Y, Kashiwara S, Fukushima K, Takada K (2011) Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats. Drug Dev Ind Pharm 37(12):1387–1393
Jarvis B, Figgitt DP (2003) Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses. Am J Clin Dermatol 4(3):203–213
Jiskoot W, Randolph TW, Volkin DB, Middaugh CR, Schoneich C, Winter G et al (2012) Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release. J Pharm Sci 101(3):946–954
Kaya G, Tran C, Sorg O, Hotz R, Grand D, Carraux P et al (2006) Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism. PLoS Med 3(12), e493
Kogan G, Soltes L, Stern R, Gemeiner P (2007) Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett 29(1):17–25
Koller J (2004) Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: a double-blind, clinical study. Drugs Exp Clin Res 30(5-6):183–190
Lai ZW, Rahim RA, Ariff AB, Mohamad R (2012) Biosynthesis of high molecular weight hyaluronic acid by Streptococcus zooepidemicus using oxygen vector and optimum impeller tip speed. J Biosci Bioeng 114(3):286–291
Lapcik L Jr, Lapcik L, De Smedt S, Demeester J, Chabrecek P (1998) Hyaluronan: preparation, structure, properties, and applications. Chem Rev 98(8):2663–2684
Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Bernier J (1997) Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 42(2):155–161
Liu S, Jin MN, Quan YS, Kamiyama F, Katsumi H, Sakane T et al (2012) The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J Control Release 161(3):933–941
Lyons RT, Robinson MR, Trogden JT, Whitcup SM, inventors (2008) Peripherally administered viscous formulations. US 20140356438 A1
Meyer J, Whitcomb L, Treuheit M, Collins D (1995) Sustained in vivo activity of recombinant human granulocyte colony stimulating factor (rHG-CSF) incorporated into hyaluronan. J Control Release 35:67–72
Milas M, Rinaudo M (2005) Characterization and properties of hyaluronic acid (hyaluronan). In: Dumitriu S (ed) Polysaccharides: structural diversity and functional versatility. Marcel Dekker, New York, pp 535–549
Mohapatra S, Yang X, Wright JA, Turley EA, Greenberg AH (1996) Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. J Exp Med 183(4):1663–1668
Moseley R, Walker M, Waddington RJ, Chen WY (2003) Comparison of the antioxidant properties of wound dressing materials--carboxymethylcellulose, hyaluronan benzyl ester and hyaluronan, towards polymorphonuclear leukocyte-derived reactive oxygen species. Biomaterials 24(9):1549–1557
Necas J, Bartosikova L, Brauner P, Kolar J (2008) Hyaluronic acid (hyaluronan): a review. Vet Med 53:397–411
Ortonne JP (2001) [Comparative study of the activity of hyaluronic acid and dextranomer in the treatment of leg ulcers of venous origin]. Annales de dermatologie et de venereologie (Suppl):13–16
Pavicic T, Gauglitz GG, Lersch P, Schwach-Abdellaoui K, Malle B, Korting HC et al (2011) Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment. J Drugs Dermatol 10(9):990–1000
Price RD, Berry MG, Navsaria HA (2007) Hyaluronic acid: the scientific and clinical evidence. J Plast Reconstr Aesthet Surg 60(10):1110–1119
Prisell PT, Camber O, Hiselius J, Norstedt G (1992) Evaluation of hyaluronan as a vehicle for peptide growth factors. Int J Pharm 85:51–60
Rossi S, Marciello M, Sandri G, Ferrari F, Bonferoni MC, Papetti A et al (2007) Wound dressings based on chitosans and hyaluronic acid for the release of chlorhexidine diacetate in skin ulcer therapy. Pharm Dev Technol 12(4):415–422
Rossler A, Hinghofer-Szalkay H (2003) Hyaluronan fragments: an information-carrying system? Horm Metab Res 35(2):67–68
Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85(8):699–715
Stern R, Kogan G, Jedrzejas MJ, Soltes L (2007) The many ways to cleave hyaluronan. Biotechnol Adv 25(6):537–557
Tanaka K, inventor (2004) Pharmaceutical composition containing viscoelastic substance and medication. US 20040038936 A1
Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279(17):17079–17084
Trommer H, Wartewig S, Bottcher R, Poppl A, Hoentsch J, Ozegowski JH et al (2003) The effects of hyaluronan and its fragments on lipid models exposed to UV irradiation. Int J Pharm 254(2):223–234
Vazquez JR, Short B, Findlow AH, Nixon BP, Boulton AJ, Armstrong DG (2003) Outcomes of hyaluronan therapy in diabetic foot wounds. Diabetes Res Clin Pract 59(2):123–127
Voelcker V, Gebhardt C, Averbeck M, Saalbach A, Wolf V, Weih F et al (2008) Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol 17(2):100–107
Voinchet V, Vasseur P, Kern J (2006) Efficacy and safety of hyaluronic acid in the management of acute wounds. Am J Clin Dermatol 7(6):353–357
Weindl G, Schaller M, Schafer-Korting M, Korting HC (2004) Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol 17(5):207–213
Witting M, Boreham A, Brodwolf R, Vávrová K, Alexiev U, Friess W et al (2015) Interactions of hyaluronic Acid with the skin and implications for the dermal delivery of biomacromolecules. Mol Pharm. 12(5):1391–401
Xie Y, Upton Z, Richards S, Rizzi SC, Leavesley DI (2011) Hyaluronic acid: evaluation as a potential delivery vehicle for vitronectin: growth factor complexes in wound healing applications. J Control Release 153(3):225–232
Yang JA, Kim ES, Kwon JH, Kim H, Shin JH, Yun SH et al (2012) Transdermal delivery of hyaluronic acid – human growth hormone conjugate. Biomaterials 33(25):5947–5954
Zavan B, Vindigni V, Vezzu K, Zorzato G, Luni C, Abatangelo G et al (2009) Hyaluronan based porous nano-particles enriched with growth factors for the treatment of ulcers: a placebo-controlled study. J Mater Sci Mater Med 20(1):235–247
Zhang LS, Greyner HJ, Mummert ME, Petroll WM (2009) Development of a hyaluronan bioconjugate for the topical treatment of melanoma. J Dermatol Sci 55(1):56–59
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hedtrich, S., Frieß, W. (2015). Hyaluronic Acid for Percutaneous Drug Delivery. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47039-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-47039-8_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47038-1
Online ISBN: 978-3-662-47039-8
eBook Packages: MedicineMedicine (R0)